Catalyst Wire Dossier Catalyst Wire Dossier

catridecacog

catridecacog · Novo Nordisk
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for catridecacog, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency [Phase 3]

See pricing